Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B

Reichen, Jürg (2006). Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B. ACP journal club, 145(1), p. 18. Philadelphia, Pa.: American College of Physicians

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Service Sector > Institute of Clinical Pharmacology and Visceral Research [discontinued]
UniBE Contributor:	Reichen, Jürg
ISSN:	1056-8751
ISBN:	16813366
Publisher:	American College of Physicians
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:45
Last Modified:	05 Dec 2022 14:14
PubMed ID:	16813366
URI:	https://boris.unibe.ch/id/eprint/18554 (FactScience: 746)